Loading...
Loading...
GENMAB A/S
GENMAB A/S. Spoken Alpha tracks GMAB's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks GMAB's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GMAB.
curl https://api.spokenalpha.com/v1/companies/GMAB| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $5.01 | $4.15 | +20.7% | +2.5% | +4.2% |
| Q4 FY2026 | $4.78 | $4.25 | +12.4% | +0.3% | -1.9% |
| Q3 FY2026 | $5.02 | $4.28 | +17.4% | -3.5% | -4.5% |
| Q2 FY2026 | $4.81 | $4.25 | +13.1% | +5.0% | +3.2% |
| Q1 FY2025 | $5.04 | $4.25 | +18.7% | -0.6% | +0.2% |
| Q4 FY2025 | $5.07 | $4.43 | +14.5% | -0.5% | +1.3% |
| Q3 FY2025 | $4.90 | $4.43 | +10.7% | -5.2% | -7.7% |
| Q2 FY2025 | $5.09 | $4.43 | +15.0% | -2.3% | -0.7% |
| Q1 FY2024 | $5.19 | $4.27 | +21.5% | +1.2% | +3.3% |
| Q4 FY2024 | $4.97 | $4.36 | +14.0% | +3.9% | +5.4% |